Cannabidiol metabolism revisited: tentative identification of novel decarbonylated metabolites of cannabidiol formed by human liver microsomes and recombinant cytochrome P450 3A4

被引：11
|
作者：
Watanabe, Kazuhito [1 ]
Usami, Noriyuki [2 ]
Osada, Shigehiro [1 ]
Narimatsu, Shizuo [3 ]
Yamamoto, Ikuo [2 ]
Yoshimura, Hidetoshi [4 ]
机构：
[1] Daiichi Univ Pharm, Minami Ku, 22-1 Tamagawa Cho, Fukuoka, Fukuoka 8158511, Japan
[2] Hokuriku Univ, Fac Pharmaceut Sci, Ho 3 Kanagawa Machi, Kanazawa, Ishikawa 9201181, Japan
[3] Minami Kyushu Univ, Fac Hlth & Nutr, 5-1-2 Kirishima, Miyazaki 8800032, Japan
[4] Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan
来源：
FORENSIC TOXICOLOGY | 2019年 / 37卷 / 02期
关键词：
Cannabidiol; Decarbonylation; Metabolism; Human liver microsomes; CYP3A4; Cyclopentadienol; CARBON-MONOXIDE; EFFICACY; EPILEPSY;
D O I：
10.1007/s11419-019-00467-0
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
PurposeThe purpose of the present study was to identify the structures of cannabidiol (CBD) metabolites during CO formation by human liver microsomes and human recombinant cytochrome P450 (CYP) enzymes.MethodsCBD was NADPH-dependently metabolized by human liver microsomes and human recombinant CYP enzymes. Less-polar metabolites were analyzed by gas chromatography-mass spectrometry monitoring, and their estimated molecular ions were m/z 286, 358 and 481 after non-derivatization, trimethylsilylation and pentafluorobenzyl oxime formation, respectively.ResultsWe tentatively identified novel decarbonylated metabolites of CBD as keto-enol tautomers. Among eight major recombinant human CYP enzymes, only CYP3A4 catalyzed the formation of decarbonylated metabolites.ConclusionsCBD was biotransformed to two decarbonylated metabolites, an enol-form (cyclopentadienol structure), and a keto-form (cyclopentenone structure) by human liver microsomes and CYP3A4.
引用
收藏
页码：449 / 455
页数：7
相关论文
共 50 条
  • [21] Identification of recombinant cytochrome P450 isoforms responsible for the in vitro metabolism of RWJ-69528 in human liver microsomes
    Gopaul, V. Sashi
    Baumgardner, Dawn
    Wu, -Nan Wu
    Streeter, Anthony
    DRUG METABOLISM REVIEWS, 2006, 38 : 196 - 197
  • [22] Metabolism of sirolimus in the presence or absence of cyclosporine by genotyped human liver microsomes and recombinant cytochromes P450 3A4 and 3A5
    Picard, Nicolas
    Djebli, Nassim
    Sauvage, Francois-Ludovic
    Marquet, Pierre
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (03) : 350 - 355
  • [23] Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human liver microsomes and nine recombinant human cytochromes P450
    Zhao, XJ
    Yokoyama, H
    Chiba, K
    Wanwimolruk, S
    Ishizaki, T
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1996, 279 (03): : 1327 - 1334
  • [24] Characterization of the NADPH-dependent metabolism of 17β-estradiol to multiple metabolites by human liver microsomes and selectively expressed human cytochrome p450 3A4 and 3A5
    Lee, AJ
    Kosh, JW
    Conney, AH
    Zhu, BT
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 298 (02): : 420 - 432
  • [25] Bioactivation of the nontricyclic antidepressant nefazodone to a reactive quinone-imine species in human liver microsomes and recombinant cytochrome P450 3A4
    Kalgutkar, AS
    Vaz, ADN
    Lame, ME
    Henne, KR
    Soglia, J
    Zhao, SX
    Abramov, YA
    Lombardo, F
    Collin, C
    Hendsch, ZS
    Hop, CECA
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (02) : 243 - 253
  • [26] Anthocyanins and their metabolites are weak inhibitors of cytochrome P450 3A4
    Dreiseitel, Andrea
    Schreier, Peter
    Oehme, Anett
    Locher, Sanja
    Hajak, Goeran
    Sand, Philipp G.
    MOLECULAR NUTRITION & FOOD RESEARCH, 2008, 52 (12) : 1428 - 1433
  • [27] Cytochrome P450 3A-mediated metabolism of buspirone in human liver microsomes
    Zhu, MS
    Zhao, WP
    Jimenez, H
    Zhang, DL
    Yeola, S
    Dai, RK
    Vachharajani, N
    Mitroka, J
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (04) : 500 - 507
  • [28] Preparative-Scale Production of Testosterone Metabolites by Human Liver Cytochrome P450 Enzyme 3A4
    Fessner, Nico D.
    Srdic, Matic
    Weber, Hansjoerg
    Schmid, Christian
    Schoenauer, David
    Schwaneberg, Ulrich
    Glieder, Anton
    ADVANCED SYNTHESIS & CATALYSIS, 2020, 362 (13) : 2725 - 2738
  • [29] In vitro characterization of the metabolism of haloperidol using recombinant cytochrome P450 enzymes and human liver microsomes
    Fang, J
    McKay, G
    Song, JX
    Remillrd, A
    Li, XM
    Midha, K
    DRUG METABOLISM AND DISPOSITION, 2001, 29 (12) : 1638 - 1643
  • [30] Interactions of cytochrome b(5) with recombinant human cytochrome P450 3A4 enhancement of catalysis
    Ueng, YF
    Johnson, WW
    Chun, YJ
    Yamazaki, H
    Shimada, T
    Martin, MV
    Guengerich, FP
    FASEB JOURNAL, 1996, 10 (06): : 2871 - 2871
12345